These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 19271459)

  • 1. [Time to abandon "the house wine". Stop for uncritical empiric use of cefuroxime].
    Hanberger H; Odenholt I; Giske CG; Kahlmeter G
    Lakartidningen; 2009 Jan 28-Feb 3; 106(5):291-2. PubMed ID: 19271459
    [No Abstract]   [Full Text] [Related]  

  • 2. [Antibiotics: new and old drugs, rational prescription].
    de With K; Stocker H; Borde J; Kern WV
    Dtsch Med Wochenschr; 2012 Feb; 137(5):186-9. PubMed ID: 22278687
    [No Abstract]   [Full Text] [Related]  

  • 3. Losing the battle of the bugs.
    Spake A
    US News World Rep; 1999 May; 126(18):52-6, 58, 60. PubMed ID: 10387461
    [No Abstract]   [Full Text] [Related]  

  • 4. Resistance to prescribing and to antibiotics.
    van Weel C; van Grunsven P
    Lancet; 1999 Sep; 354(9184):1052. PubMed ID: 10509494
    [No Abstract]   [Full Text] [Related]  

  • 5. Estimation of cefuroxime dosage using pharmacodynamic targets, MIC distributions, and minimization of a risk function.
    Viberg A; Cars O; Karlsson MO; Jönsson S
    J Clin Pharmacol; 2008 Nov; 48(11):1270-81. PubMed ID: 18974282
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Principles of antimicrobial therapy.
    Boothe DM
    Vet Clin North Am Small Anim Pract; 2006 Sep; 36(5):1003-47, vi. PubMed ID: 16984825
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clindamycin (Dalacin C).
    Drug Ther Bull; 1970 Aug; 8(17):67-8. PubMed ID: 5480245
    [No Abstract]   [Full Text] [Related]  

  • 8. The jury is still out on continuous infusion of beta-lactam antibiotics in intensive care patients.
    van Zanten AR
    Crit Care Med; 2009 Jun; 37(6):2137-8. PubMed ID: 19448477
    [No Abstract]   [Full Text] [Related]  

  • 9. [To be or not to be for cefuroxime].
    Gårdlund B; Kalin M
    Lakartidningen; 2009 Sep 16-22; 106(38):2382-3; author reply 2383-4. PubMed ID: 19848348
    [No Abstract]   [Full Text] [Related]  

  • 10. Resistance linked to antibiotic misuse.
    Aust Nurs J; 2001 Jul; 9(1):34. PubMed ID: 11908324
    [No Abstract]   [Full Text] [Related]  

  • 11. Comparison of the antimicrobial activity of cefuroxime with other oral antibiotics.
    Wiedemann B; Heisig P
    J Chemother; 1989 Jul; 1(4 Suppl):93-6. PubMed ID: 16312320
    [No Abstract]   [Full Text] [Related]  

  • 12. Influence of different resistance traits on the competitive growth of Haemophilus influenzae in antibiotic-free medium and selection of resistant populations by different {beta}-lactams: an in vitro pharmacodynamic approach.
    González N; Aguilar L; Alou L; Giménez MJ; Sevillano D; Torrico M; Cafini F; Coronel P; Prieto J
    J Antimicrob Chemother; 2009 Jun; 63(6):1215-22. PubMed ID: 19307171
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cefuroxime usage and resistance, the Swedish experience.
    Burman LG
    J Chemother; 1989 Jul; 1(4 Suppl):296-8. PubMed ID: 16312408
    [No Abstract]   [Full Text] [Related]  

  • 14. Streptococcus pneumoniae: does antimicrobial resistance matter?
    Lynch JP; Zhanel GG
    Semin Respir Crit Care Med; 2009 Apr; 30(2):210-38. PubMed ID: 19296420
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Current clinical problems in evaluating microbiological and pharmacological data].
    Aguado JM
    Enferm Infecc Microbiol Clin; 1995 Oct; 13(8):477-81. PubMed ID: 8555308
    [No Abstract]   [Full Text] [Related]  

  • 16. [Josamycin propionate. 1. Physicochemical and biological properties].
    Osono T; Yano K; Murakami K; Miyamoto F; Murakami K
    Jpn J Antibiot; 1973 Apr; 26(2):115-21. PubMed ID: 4542537
    [No Abstract]   [Full Text] [Related]  

  • 17. Interplay of efflux, impermeability, and AmpC activity contributes to cefuroxime resistance in clinical, non-ESBL-producing isolates of Escherichia coli.
    Källman O; Giske CG; Samuelsen Ø; Wretlind B; Kalin M; Olsson-Liljequist B
    Microb Drug Resist; 2009 Jun; 15(2):91-5. PubMed ID: 19432520
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Failures of beta-lactam therapy for invasive pneumococcal disease.
    Klugman KP
    Pediatr Infect Dis J; 2004 Oct; 23(10):980-1; author reply 981. PubMed ID: 15602214
    [No Abstract]   [Full Text] [Related]  

  • 19. Antimicrobial susceptibility of Streptococcus pneumoniae at a university hospital in Taiwan, 2000-07: impact of modified non-meningeal penicillin breakpoints in CLSI M100-S18.
    Su LH; Wu TL; Kuo AJ; Chia JH; Chiu CH
    J Antimicrob Chemother; 2009 Aug; 64(2):336-42. PubMed ID: 19520718
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Empiric antimicrobial therapy for pediatric skin and soft-tissue infections in the era of methicillin-resistant Staphylococcus aureus.
    Elliott DJ; Zaoutis TE; Troxel AB; Loh A; Keren R
    Pediatrics; 2009 Jun; 123(6):e959-66. PubMed ID: 19470525
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.